Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic testing may avoid abacavir hypersensitivity reaction.

John S James

    AIDS Treatment News
    |November 14, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activism and online fundraising: overview.

    AIDS treatment news·2007
    Same author

    "Fundathon": toward massively multiplayer online fundraising games.

    AIDS treatment news·2007
    Same authorSame journal

    Selling digital art in bulk through prepaid URLs.

    AIDS treatment news·2007
    Same authorSame journal

    Financial accounts that can reproduce, inherit, and evolve.

    AIDS treatment news·2007
    Same authorSame journal

    AIDS search engine wanted: what to do now?

    AIDS treatment news·2007
    Same author

    Prisoner death rate very high immediately after release.

    AIDS treatment news·2007

    An experimental genetic test can identify patients at risk for abacavir hypersensitivity reactions. This test aims to prevent severe reactions in approximately 5% of individuals starting this medication.

    Area of Science:

    • Pharmacogenetics
    • Immunology
    • Drug Hypersensitivity

    Background:

    • Abacavir is a crucial antiretroviral medication used in HIV treatment.
    • Hypersensitivity reactions (HVR) to abacavir affect about 5% of patients.
    • These reactions can be severe and life-threatening, necessitating early identification of at-risk individuals.

    Discussion:

    • The development of a predictive genetic test for abacavir HVR is a significant advancement.
    • This test targets specific genetic markers associated with abacavir hypersensitivity.
    • Early identification allows for proactive management and alternative treatment strategies.

    Key Insights:

    • An experimental genetic test demonstrates high efficacy in predicting abacavir hypersensitivity.
    • The test can identify individuals likely to experience HVR before treatment initiation.

    Related Experiment Videos

  • This preemptive approach has the potential to nearly eliminate abacavir-induced hypersensitivity reactions.

    • Outlook:

    • Widespread clinical implementation of this genetic test could significantly improve patient safety.
    • Further research may explore similar genetic screening for other drug-induced hypersensitivities.
    • This pharmacogenetic approach represents a personalized medicine strategy for antiretroviral therapy.